Abingworth LLP Obs Eva Sa Transaction History

Abingworth LLP

  • $301 Million
  • Q4 2022

A detailed history of Abingworth LLP transactions in Obs Eva Sa stock. As of the latest transaction made, Abingworth LLP holds 87,999 shares of OBSV stock, worth $0. This represents 0.0% of its overall portfolio holdings.

Number of Shares
87,999
Previous 87,999 -0.0%
Holding current value
$0
Previous $13,000 7.69%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2019

May 15, 2019
SELL
$11.82 - $14.48 $4.16 Million - $5.1 Million
-352,001 Reduced 80.0%
87,999 $1.12 Million
Q3 2017

Nov 14, 2017
BUY
$6.38 - $8.14 $2.81 Million - $3.58 Million
440,000
440,000 $3.48 Million

Others Institutions Holding OBSV

# of Institutions
2
Shares Held
88K
Call Options Held
0
Put Options Held
0
View Full List

About ObsEva SA

OBSV Quotes by TradingView
  • Ticker OBSV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 84,499,200
  • Description
  • ObsEva SA, a biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for women suffering from reproductive health and pregnancy. It is developing Linzagolix, an oral gonadotropin releasing hormone receptor antagonist that is in Phase III clinical trial for the treatment of pain associated with endometrio...
More about OBSV
Track This Portfolio

Track Abingworth LLP Portfolio

Follow Abingworth LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Abingworth LLP, based on Form 13F filings with the SEC.

News

Stay updated on Abingworth LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email